The Antihemophilic Factor,recombinan, cataloged under National Stock Number 6505-01-585-8595, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Novo Nordisk Inc. Government technical data includes 2 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Cancelled. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-585-8595 |
| Primary Part Number | NDC00169-7050-01 |
| Item Name | Antihemophilic Factor,recombinan |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Novo Nordisk Inc |
| Status | CANCELLED |
| Immediate Container Type | VIAL |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS OR REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS |
| Acquisition Status | CANCELLED |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC00169-7050-01 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| NDC00169-7050-01 PRIMARY | Novo Nordisk Inc (USA) |
| Reference | Meaning |
|---|---|
| 16898 | 5/1 Secondary reference U.S. Government activity |
| NOVO SEVEN | 5/1 Secondary reference Novo Nordisk Inc |
| 6505NCM104585 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-585-8595 is a Antihemophilic Factor,recombinan, manufactured by Novo Nordisk Inc, classified under FSC 6505, Drugs and Biologicals. Status: cancelled.
NSN 6505-01-585-8595 has 2 manufacturer part numbers on file: NDC00169-7050-01 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office), NDC00169-7050-01 (Novo Nordisk Inc).
Key specifications for NDC00169-7050-01: Immediate Container Type: VIAL; Special Features: RECOMB (BHK CELLS); 5 MG FACTOR VIIA LYOPHILIZED POWDER PER GLASS VIAL (5000 MICROGRAMS/VIAL); PRESERVATIVE FREE; PRIOR TO RECONSTITUTION, KEEP REFRIGERATED OR STORE BETWEEN 2 TO 25 DEG C; AFTER RECONSTITUTION, MAY BE STORED EITHER AT ROOM TEMP OR REFRIGERATED UP TO 3 HRS; DO NOT FREEZE; PROTECT FROM LIGHT; DILUENT: 10 MMOL SOLUTION L-HISTIDINE IN WATER FOR INJECTION; LATEX FREE; CHLOROBUTYL RUBBER STOPPER SEALED WITH AN ALUMINUM CAP; DO NOT FREEZE AFTER RECONSTITUTION OR STORE IT IN SYRINGES; FOR INTRAVENOUS BOLUS INJECTION ONLY; USED IN TREATMENT OF BLEEDING EPISODES IN HEMOPHILIA A OR B WITH INHIBITORS IN ACQUIRED HEMOPHILIA AND IN SURGICAL INTERVENTIONS OR INVASIVE PROCEDURES IN CONGENITAL FVII DEFICIENCY DEGC; Protective Storage Feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS OR REQUIRES CONTROLLED ROOM TEMPERATURE STORAGE BETWEEN 15 TO 30 DEG CELSIUS; Part Name Assigned by Controlling Agency: ANTIHEMOPHILIC FACTOR VIIA NOVOSEVEN 5000MCG VIAL. 2 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
NSN 6505-01-585-8595 is currently cancelled. Check with the Defense Logistics Agency for current availability and authorized substitutes.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.